✦ LIBER ✦

Resistance to Imatinib: Mutations and Beyond

✍ Scribed by Paul La Rosée; Michael W. Deininger

Book ID: 117822209
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 478 KB
Volume: 47
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2010.06.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance to imatinib: more and more mu

Resistance to imatinib: more and more mutations

✍ Sawyers, C. L. 📂 Article 📅 2003 🏛 American Society of Hematology 🌐 English ⚖ 26 KB

BCR-ABL mutations and resistance to imat

BCR-ABL mutations and resistance to imatinib mesylate in Ph+ leukaemia

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

CML patients with imatinib-resistant mut

CML patients with imatinib-resistant mutations responsive to dasatinib and nilotinib

📂 Article 📅 2007 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 63 KB

KRAS and BRAF Mutations Predict Primary

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

✍ Miranda, C.; Nucifora, M.; Molinari, F.; Conca, E.; Anania, M. C.; Bordoni, A.; 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 883 KB

Acquired resistance to imatinib in gastr

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

✍ Eva Wardelmann; Nadja Thomas; Sabine Merkelbach-Bruse; Katharina Pauls; Nicola S 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 163 KB

Novel V600E BRAF mutations in imatinib-n

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

✍ Narasimhan P. Agaram; Grace C. Wong; Tianhua Guo; Robert G. Maki; Samuel Singer; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

## Abstract __BRAF__ and __NRAS__ are commonly mutated in cancer and represent the most frequent genetic events in malignant melanoma. More recently, a subset of melanomas was shown to overexpress KIT and harbor __KIT__ mutations. Although most gastrointestinal stromal tumors (GISTs) exhibit activa